Fietze Ingo, Blau Alexander, Glos Martin, Theres Heinz, Baumann Gert, Penzel Thomas
Charite-Universitätsmedizin Berlin, CCM, Department of Internal Medicine, Center for Sleep Medicine, Luisenstr. 13, D-10117 Berlin, Germany.
Sleep Med. 2008 Aug;9(6):652-9. doi: 10.1016/j.sleep.2007.09.008. Epub 2007 Nov 19.
Nocturnal positive pressure ventilation (PPV) has been shown to be effective in patients with impaired left ventricular ejection fraction (LVEF) and Cheyne-Stokes respiration (CSR). We investigated the effect of a bi-level PPV and adaptive servo ventilation on LVEF, CSR, and quantitative sleep quality.
Thirty-seven patients (New York heart association [NYHA] II-III) with LVEF<45% and CSR were investigated by electrocardiography (ECG), echocardiography and polysomnography. The CSR index (CSRI) was 32.3+/-16.2/h. Patients were randomly treated with bi-level PPV using the standard spontaneous/timed (S/T) mode or with adaptive servo ventilation mode (AutoSetCS). After 6 weeks, 30 patients underwent control investigations with ECG, echocardiography, and polysomnography.
The CSRI decreased significantly to 13.6+/-13.4/h. LVEF increased significantly after 6 weeks of ventilation (from 25.1+/-8.5 to 28.8+/-9.8%, p<0.01). The number of respiratory-related arousals decreased significantly. Other quantitative sleep parameters did not change. The Epworth sleepiness score improved slightly. Daytime blood pressure and heart rate did not change. There were some differences between bi-level PPV and adaptive servo ventilation: the CSRI decreased more in the AutoSetCS group while the LVEF increased more in the bi-level PPV group.
Administration of PPV can successfully attenuate CSA. Reduced CSA may be associated with improved LVEF; however, this may depend on the mode of PPV. Changed LVEF is evident even in the absence of significant changes in blood pressure.
夜间正压通气(PPV)已被证明对左心室射血分数(LVEF)受损和陈-施呼吸(CSR)患者有效。我们研究了双水平PPV和适应性伺服通气对LVEF、CSR和定量睡眠质量的影响。
对37例左心室射血分数<45%且有CSR的患者(纽约心脏协会[NYHA]II-III级)进行心电图(ECG)、超声心动图和多导睡眠图检查。CSR指数(CSRI)为32.3±16.2/小时。患者被随机分为使用标准自主/定时(S/T)模式的双水平PPV治疗组或适应性伺服通气模式(AutoSetCS)治疗组。6周后,30例患者接受了ECG、超声心动图和多导睡眠图的对照检查。
CSRI显著降低至13.6±13.4/小时。通气6周后LVEF显著增加(从25.1±8.5%增至28.8±9.8%,p<0.01)。与呼吸相关的觉醒次数显著减少。其他定量睡眠参数未改变。爱泼华嗜睡量表评分略有改善。日间血压和心率未改变。双水平PPV和适应性伺服通气之间存在一些差异:AutoSetCS组的CSRI下降更多,而双水平PPV组的LVEF增加更多。
PPV治疗可成功减轻中枢性睡眠呼吸暂停(CSA)。CSA减轻可能与LVEF改善有关;然而,这可能取决于PPV的模式。即使血压无显著变化,LVEF的改变也很明显。